Results 111 to 120 of about 4,397,412 (173)

Psoriasis Treatment Success With Bimekizumab: Two Hard-to-Treat Cases. [PDF]

Cureus
Ameen A.
europepmc   +1 more source

The Definition of Psoriasis Severity and Treatment Target of Psoriasis: Korean Expert Consensus Using the Modified Delphi Method. [PDF]

Ann Dermatol
Bang CH, Baek YS, Kim TG, Jeong KH, Kim JE, Jo SJ, Lee ES, Choe YB, Korean Society for Psoriasis.   +8 more
europepmc   +1 more source

Association between adiposity and psoriatic arthritis beyond classical clinical predictors. [PDF]

Clin Rheumatol
Pardo E, Burger S, Loredo M, Braña I, Alvarez P, Queiro R.   +5 more
europepmc   +1 more source

Tildrakizumab in the Treatment of Complex and Severe Psoriasis: A Case Series. [PDF]

J Clin Med
Marasca C, D'Amico D, Giofrè C, Lora V.
europepmc   +1 more source

Comparison of clinical and dermoscopical nail findings of rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and psoriasis: A prospective study. [PDF]

Medicine (Baltimore)
Güneş B, Yurdakul OV, Tak AY, Yilmaz N, Küçük ÖS, Onsun N.   +5 more
europepmc   +1 more source

Real-life effectiveness and safety of bimekizumab in patients with moderate plaque psoriasis: a 54-week multicentre study in the Lazio region. [PDF]

Drugs Context
Feresin F, Bernardini N, Campione E, Caldarola G, Gubinelli E, Moretta G, Pagnanelli G, Giordano D, Persechino S, Falco GM, Artosi F, Zappia E, Pellacani G, Potenza C, Richetta AG, De Simone C, Orsini D, Dattola A.   +17 more
europepmc   +1 more source

Psoriasis patients with psoriatic arthritis demonstrate a reduced regulatory capacity for neutrophil elastase. [PDF]

Rheumatology (Oxford)
Macleod T, Dubash SR, Hyde I, Michelena X, Berekmeri A, Helliwell PS, Kingsbury SR, Laws P, Mankia K, Stacey M, Marzo-Ortega H, Wittmann M.   +11 more
europepmc   +1 more source

Marked improvement of isolated acrodermatitis continua of hallopeau with upadacitinib: a case report and literature review. [PDF]

Front Med (Lausanne)
Li M, Zhang GX, Wu YL, Huang HY.
europepmc   +1 more source

Efficacy and safety of different doses of apremilast in mild to-moderate psoriasis: A randomized controlled study. [PDF]

Indian J Pharmacol
Anil A, Saravanan A, Budania A, Yadav I, Dwivedi P, Varthya SB, Ambwani S, Singh S.   +7 more
europepmc   +1 more source

The Evaluation of the Clinical Effectiveness and Safety of Biologic Therapies in Psoriasis-Real-World Evidence up to 64 Weeks of Therapy. [PDF]

Med Sci (Basel)
Lemiesz P, Nowowiejska-Purpurowicz J, Kaminski TW, Flisiak I.   +3 more
europepmc   +1 more source